Armata Pharmaceuticals, Inc. Common Stock (ARMP) is a publicly traded Healthcare sector company. As of November 12, 2026, ARMP trades at $3.77 with a market cap of $144.64M and a P/E ratio of -0.72. ARMP moved -4.37% today. Year to date, ARMP is -40.36%; over the trailing twelve months it is -43.39%. Its 52-week range spans $0.90 to $16.34. Analyst consensus is buy with an average price target of $17.50. Rallies surfaces ARMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ARMP, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $3.77 |
| Market Cap | $144.64M |
| P/E Ratio | -0.72 |
| EPS | $-5.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.34 |
| 52-Week Low | $0.90 |
| Volume | 93.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.54M |
| Net Income | $-192.18M |
| Gross Margin | 0.00% |
2 analysts cover ARMP: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.50.